Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastrointest Surg. Jun 27, 2016; 8(6): 444-451
Published online Jun 27, 2016. doi: 10.4240/wjgs.v8.i6.444
Table 1 Co-morbidity and possible risk factors
Symptomsn (%)
Abdominal pain80 (100)
Dyspepsia65 (81)
Heart burn29 (36)
Dysphagia17 (21)
Palpable mass7 (9)
Co-morbidity
Helicobacter pylori66 (83)
Smokers56 (70)
Diabetes mellitus16 (20)
Hypertension16 (20)
Total80 (100)
Table 2 Preoperative endoscopic evaluation
Itemn (%)
Site of tumor:
Antrum51 (64)
Body19 (24)
Fundus10 (12)
Macroscopic feature:
Exophytic growth46 (58)
Ulcerative form34 (42)
Diffuse form0
Total80 (100)
Table 3 Complications after gastrectomy
n (%)
Anastomotic leakage3 (4)
Internal hemorrhage1 (1)
Splenic bed collection2 (3)
Pleural effusion2 (3)
Wound infection2 (3)
Total10 (13)
Table 4 Pattern of recurrence
Itemn (%)
Local recurrence9 (11)
Lymph nodes metastasis2 (3)
Liver metastasis2 (3)
Total13 (16)
Table 5 Demographic and clinicopathological features predicting overall survival
CharacteristicsNumber of patients n (%)Months after surgery (mean ± SD)P value
Sex
Male57 (71)50.2 ± 3.1
Female23 (29)47.8 ± 4.6P = 0.830
Age
Below 6049 (61)47.3 ± 3.5
Above 6031 (39)53.6 ± 3.6P = 0.259
Site
Antrum51 (64)47 ± 3.5
Body19 (24)57.2 ± 3.5
Fundus10 (12)40.3 ± 6P = 0.315
Type of surgery
Total gastrectomy3065 ± 7
Subtotal gastrectomy5060P = 0.548
Tumor differentiation
Well37 (46)65.6 ± 0.3
Moderate20 (25)50.8 ± 5.3
Poor23 (29)20.8 ± 4P = 0.001
T stage
T110 (13)60 ± 3.2
T225 (31)60 ± 2.4
T329 (36)61 ± 3
T416 (20)12 ± 2.3P = 0.001
LN ratio
07 (9)61
≤ 0.220 (25)62 ± 2.5
0.2-0.426 (32)62 ± 2.1
> 0.427 (34)22 ± 4.5P < 0.001
LN status
Negative7 (9)61 ± 3.5
Positive73 (91)31 ± 2.3P = 0.03
Number of examined LN
> 1565 (81)54.48 ± 2.6
≤ 1515 (19)14.5 ± 1P < 0.001
Surgical margin
Negative73 (91)53.8 + 2.4
Positive7 (9)9.5 + 1P < 0.001
Recurrence
No67 (84)57.3 + 2.3
Yes13 (16)12.3 + 1.2P < 0.001
Table 6 Multivariate analysis
FactorsOdds ratioCI lower-upperP value
Tumor differentiation0.1420.045-1.0920.044
Radicality of resection2.571.4-5.10.001
Number of resected lymph node > 152.041.3-3.750.001
Table 7 Published series on prognostic factors after resection for gastric carcinoma
Ref.PeriodNo.GenderAgeLocationNo. excised NLLN ratioT stageHistologic typeN stageCurative resection
Adachi et al[45]1977-1987479NSNSP < 0.01P < 0.01NRP < 0.01P < 0.01P < 0.01NR
Bando et al[27]1974-1995650NRNRNRP < 0.001P < 0.001P < 0.001NSNRNR
Yokota et al[46]1985-1995926NS 0.347NS 0.099P < 0.0001NRNRP < 0.0001P < 0.0001P < 0.0001NR
Angelov et al[47]2005-2013101NS 0.587NS 0.67NS 0.54NRNRNRNR 0.169P = 0.003P < 0.001
Basaran et al[48]2006-2014228NSP < 0.0001P < 0.001NRNRNS 0.137P < 0.015P < 0.002P = 0.000
Present study2009-201380NS 0.83NS 0.259NS 0.315P < 0.001P < 0.001P = 0.001P = 0.001NRP < 0.001